Programmable Biomaterials Usher in New Vaccine Era

December 11, 2014

(Genetic Engineering & Biotechnology News) – Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard’s School of Engineering and Applied Sciences (SEAS) report that a nonsurgical injection of a programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their study (“Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy”) is published in Nature Biotechnology.